Hormone replacement therapy in relation to breast cancer

JAMA

Volumn 287, Issue 6, 2002, Pages 734-741

  Chen, Chi Ling ^a   Weiss, Noel S ^a   Newcomb, Polly ^a   Barlow, William ^a   White, Emily ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; INVASIVE CARCINOMA; LONG TERM CARE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0037070255     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.6.734     Document Type: Article

References (47)

1. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
2. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
3. The risk of breast cancer after estrogen and estrogenprogestin replacement
4. Menopausal hormone usage and breast cancer in Saskatchewan: A record-linkage cohort study
5. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists
6. Exogenous hormone and the risk of postmenopausal breast cancer: Results from the Netherlands cohort study
7. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users
8. Replacement estrogens and breast cancer
9. Breast-cancer risk following long-term oestrogen and oestrogen-progestin-replacement therapy
10. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
11. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women
12. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women
13. Noncontraceptive hormone use and risk of breast cancer
14. Breast cancer risk after estrogen replacement therapy: Results from the Toronto Breast Cancer Study
15. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark
16. Non-contraceptive oestrogens and breast cancer
17. Hormone replacement treatment and breast cancer risk: A cooperative Italian study
18. Breast cancer and estrogen replacement therapy
19. Estrogen replacement therapy and the risk of breast cancer: Results from the case-control surveillance study
20. Oestrogen replacement therapy and breast cancer risk: A case-control study
21. Breast cancer risk: Effects of estrogen replacement therapy and body mass
22. Exogenous estrogen and breast cancer after bilateral oophorectomy
23. Menopausal estrogens and breast cancer risk: An expanded case-control study
24. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: A case-control study in Greece
25. The association of replacement estrogens with breast cancer
26. Reproductive and hormonal factors and breast cancer in a Northern Italian population
27. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy
28. Hormone replacement therapy and the risk of breast cancer: Nested case-control study in a cohort of Swedish women attending mammography screening
29. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
30. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women
31. Post-menopausal hormone use and risk of breast cancer by histologic type
32. Risk based breast cancer screening at Group Health Cooperative of Puget Sound
33. Mammography diffusion and trends in late-stage breast cancer: Evaluating outcomes in populations
34. Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women
35. Changing incidence rate of invasive lobular breast carcinoma among older women
36. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis
37. Reproductive factors and breast cancer
38. Increased cell division as a cause of human cancer
39. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
40. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer
41. Oral contraceptive use influences resting breast proliferation
42. Progestin regulation of cellular proliferation
43. Physiological action of progesterone in target tissues
44. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast
45. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer: Correlation of histopathology and prognostic factors
46. Infiltrating lobular carcinoma of the breast
47. Invasive lobuar and ductal carcinoma: Mammographic findings and stage at diagnosis